Anal cancer: One step forward - Two steps sideways!

European Journal of Cancer

Volumn 45, Issue 16, 2009, Pages 2728-2730

  Glynne Jones, R ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE; FLUOROURACIL; GEMCITABINE; MITOMYCIN C; NAVELBINE; PACLITAXEL; TOPOTECAN;

ANUS CARCINOMA; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTINUOUS INFUSION; HUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIZATION; SEX DIFFERENCE; SQUAMOUS CELL CARCINOMA; TREATMENT DURATION; TREATMENT RESPONSE; TUMOR VOLUME; UTERINE CERVIX CANCER;

EID: 70350010374     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.08.017     Document Type: Note

References (12)

1. Ajani J.A., Winter K.A., Gunderson L.L., et al. Fluorouracil, mitomycin and radiotherapy vs fluorouracil, cisplatin and radiotherapy for carcinoma of the anal canal: a randomised controlled trial. JAMA 199 (2008) 1914-1921
2. James R., Wan S., Glynne-Jones R., et al. A randomised trial of chemoradiation using mitomycin or cisplatin, with or without maintenance cisplatin/5FU in squamous cell carcinoma of the anus (ACT II). J Clin Oncol 27 (2009) 18s [Suppl.; abstr. LBA4009]
3. Conroy T., Ducreux M., and Lemanski C. ACCORD J Clin Oncol 27 (2009) 15s [Suppl.; abstr. 4033]
4. Flam M., John M., Pajak T.F., et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomised intergroup. J Clin Oncol 14 (1996) 2527-2539
5. Bosset J.F., Roelefsen F., Morgan D., et al. Shortened irradiation scheme, continuous infusion of fluorouracil in locally advanced anal carcinomas: results of a phase II study of the European Organisation for Research and Treatment of Cancer. Eur J Cancer 39 (2003) 45-51
6. Bartelink H., Roelofsen F., Eschwege F., et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomised trial of the European Organisation for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15 (1997) 2040-2049
7. UKCCCR Anal Cancer Working Party. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil and mitomycin C. Lancet 348 (1996) 1049-1054
8. Chapet O., Gerard J.P., Riche B., et al. Prognostic value of tumour regression evaluated after first course of radiotherapy for anal canal cancer. Int J Radiat Oncol Biol Phys 63 (2005) 1316-1324
9. Doci R., Zucali R., La Monica G., et al. Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients. J Clin Oncol 14 (1996) 3121-3125
10. Gerard J.P., Ayzac L., Hun D., et al. Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum: long term results in 95 patients. Radiother Oncol 46 (1998) 249-256
11. Weber D.C., Kurtz J.M., and Allal A.S. The impact of gap duration on local control in anal canal carcinoma treated by split-course radiotherapy and concomitant chemotherapy. Int J Radiat Oncol Biol Phys 50 (2001) 675-680
12. Konski A., Garcia M., John M., et al. Evaluation of planned treatment breaks during radiation therapy for anal cancer: update of RTOG 92-08. Int J Radiat Oncol Biol Phys 72 1 (2008) 114-118